Full Text View
Tabular View
No Study Results Posted
Related Studies
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole (SIP)
This study is not yet open for participant recruitment.
Verified June 2010 by Feinstein Institute for Medical Research
Study NCT01155544   Information provided by Feinstein Institute for Medical Research

First Received on July 1, 2010.   Last Updated on May 27, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Substance Abuse
Substance Dependence
Additional conditions recognized in this trial
Psychotic Disorders
Substance-Related Disorders
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Behavioral Intervention
Additional drug interventions recognized in this trial
Aripiprazole
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Feinstein Institute for Medical Research
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services